Advisor Group Holdings, Inc. Heron Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,409 shares of HRTX stock, worth $2,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,409

Previous 1,674 15.83%

Holding current value

$2,183

Previous $5,000 60.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.73 - $3.67 $458 - $972	-265 Reduced 15.83%	1,409 $2,000
Q2 2024 Aug 13, 2024	SELL	$2.32 - $3.86 $35,978 - $59,860	-15,508 Reduced 90.26%	1,674 $5,000
Q1 2024 May 10, 2024	BUY	$1.71 - $3.06 $1,723 - $3,084	1,008 Added 6.23%	17,182 $47,000
Q4 2023 Feb 12, 2024	SELL	$0.54 - $1.82 $1,611 - $5,430	-2,984 Reduced 15.58%	16,174 $27,000
Q3 2023 Nov 13, 2023	SELL	$0.97 - $1.8 $251 - $466	-259 Reduced 1.33%	19,158 $19,000
Q2 2023 Aug 10, 2023	SELL	$1.11 - $2.88 $1,743 - $4,524	-1,571 Reduced 7.49%	19,417 $22,000
Q1 2023 May 12, 2023	SELL	$1.51 - $3.25 $906 - $1,950	-600 Reduced 2.78%	20,988 $31,000
Q4 2022 Feb 10, 2023	BUY	$2.25 - $4.67 $3,017 - $6,262	1,341 Added 6.62%	21,588 $53,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $2,008 - $4,054	-755 Reduced 3.59%	20,247 $85,000
Q2 2022 Aug 10, 2022	BUY	$2.3 - $6.29 $1,948 - $5,327	847 Added 4.2%	21,002 $58,000
Q1 2022 May 04, 2022	SELL	$4.63 - $9.94 $103,415 - $222,019	-22,336 Reduced 52.57%	20,155 $115,000
Q3 2021 Nov 05, 2021	BUY	$10.13 - $15.0 $5,551 - $8,220	548 Added 1.31%	42,491 $456,000
Q2 2021 Aug 02, 2021	BUY	$13.27 - $18.48 $136,787 - $190,491	10,308 Added 32.58%	41,943 $652,000
Q1 2021 May 13, 2021	BUY	$14.49 - $20.72 $304,855 - $435,928	21,039 Added 198.56%	31,635 $513,000
Q4 2020 Feb 10, 2021	BUY	$14.61 - $22.14 $30,695 - $46,516	2,101 Added 24.73%	10,596 $223,000
Q3 2020 Nov 12, 2020	SELL	$13.67 - $17.77 $3,048 - $3,962	-223 Reduced 2.56%	8,495 $126,000
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $73,507 - $144,922	6,750 Added 342.99%	8,718 $128,000
Q1 2020 May 18, 2020	BUY	$10.23 - $24.56 $20,132 - $48,334	1,968 New	1,968 $23,000

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Heron Therapeutics, Inc. Transaction History